Comparison of various methods for processing cascade impactor data

Aerosol Science and Technology

Volumn 40, Issue 9, 2006, Pages 672-682

  Majoral, C ^a,b   Le Pape, A ^a   Diot, P ^a   Vecellio, L ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AEROSOLS; CASCADE CONTROL SYSTEMS; MATRIX ALGEBRA; PARTICLE SIZE ANALYSIS; PROBABILITY DISTRIBUTIONS; STATISTICAL METHODS;

CASCADE IMPACTOR DATA; MATRIX METHOD; NEBULIZERS; SODIUM FLUORIDE AEROSOLS;

DATA PROCESSING;

FLUORIDE SODIUM;

AEROSOL; ANALYTIC METHOD; ARTICLE; BREATHING; INHALER; INTERMETHOD COMPARISON; NEBULIZER; PARTICLE SIZE; PRIORITY JOURNAL;

EID: 33745415042     PISSN: 02786826     EISSN: 15217388     Source Type: Journal    
DOI: 10.1080/02786820600796582     Document Type: Article

References (25)

1. Aug, C., Perry, R. J., and Smaldone, G. C. (1991). Technetium 99m Radiolabeling of Aerosolized Drug Particles from Metered Dose Inhalers, J. Aerosol Med. 4:127-138.
2. Dunbar, C. A. and Hickey, A. J. (2000). Evaluation of Probability Density Functions to Approximate Particle Size Distributions of Representative Pharmaceutical Aerosols, J. Aerosol Sci. 31:813-831.
3. Dunbar, C. and Mitchell, J. (2005). Analysis of Cascade Impactor Mass Distributions, J. Aerosol Med. 18:439-451.
4. EN 13544-1 (2001). Respiratory therapy equipment - Part 1: Nebulising systems and their components. Official Journal of the European Union.
5. EN 1822-1 (1998). High efficiency air filters (HEPA and ULPA). Classification, performance testing, marking. British-Adopted European Standard.
6. European Pharmacopeia (2002). Chapter 2.9.18 - Preparations for inhalation: Aerodynamic assessment of fine particles. European Pharmacopeia. 3rd ed. [Suppl 2001]. Council of Europe: Strasbourg, France.
7. Ferron, G. A. (1977). The Size of Soluble Aerosol Particles as a Function of the Humidity of the Air. Application to the Human Respiratory Tract, J. Aerosol Sci. 8:251-267.
8. Heyder, J., Gebhart, J., Rudolf, G., and Stahlhofen, W. (1980). Physical Factors Determining Particle Deposition in the Human Respiratory Tract, J. Aerosol Sci. 11:505-515.
9. Heyder, J., Gebhart, J., and Scheuch, G. (1988). Influence of Human Lung Morphology on Particle Deposition, J. Aerosol Med. 1:81-88.
10. Iula, A. K., Flynn, C. L., and Deluccia, F. (1997). Comparative Study of the In Vitro Dose Delivery and Particle Size Distribution Characteristics of An Azmacort Metered-dose Inhaler in Combination with Four Different Spacer Devices, Curr. Ther. Res. 58:544-554.
11. Kwong, W. T. J., Ho, S. L., and Coates, A. L. (2000). Comparison of Nebulized Particle Size Distribution with Malvern Laser Diffraction Analyser versus Andersen Cascade Impactor and Low-Flow Marple Personal Cascade Impactor, J. Aerosol Med. 13:303-314.
12. Leach, C. L., Davidson, P. J., Hasselquist, B. E., and Boudreau, R. J. (2005). Influence of Particle Size and Patient Dosing Technique on Lung Deposition of HFA-Beclomethasone from a Metered Dose Inhaler, J. Aerosol Med. 18:379-385.
13. Leung, K., Louca, E., Gray, M., Tipples, G., and Coates, A. L. (2005). Use of the Next Generation Pharmaceutical Impactor for Particle Size Distribution Measurements of Live Viral Aerosol Vaccines, J. Aerosol Med. 18:414-426.
14. Marple, V. A. (1970). A Fundamental Study of Inertial Impactors. Ph.D. thesis, University of Minnesota, Minneapolis.
15. Marple, V. A., Olson, B. A., Santhanakrishnan, K., Mitchell, J. P., Murray, S. C., and Hudson-Curtis, B. L. (2003). Next Generation Pharmaceutical Impactor (A New Impactor for Pharmaceutical Inhaler Testing). Part II: Archival Calibration, J. Aerosol Med. 16:301-324.
16. Mitchell, J. P., Costa, P. A., and Waters, S. (1988). An Assessment of An Andersen Mark-II Cascade Impactor, J. Aerosol Sci. 19:213-221.
17. Mitchell, J. P. and Nagel, M. W. (2003). Cascade Impactors for the Size Characterization of Aerosols from Medical Inhalers: Their Uses and Limitations, J. Aerosol Med. 16:341-377.
18. Morrow, P. E. (1974). Conference on the Scientific Basis of Respiratory Therapy. Aerosol Therapy. Aerosol Characterization and Deposition, Am Rev Respir Dis. 110:88-99.
19. O'Shaughnessy, P. T. and Raabe, O. G. (2003). A Comparison of Cascade Impactor Data Reduction Methods, Aerosol Sci. Technol. 37:187-200.
20. Picknett, R. G. (1972). A New Method of Determining Aerosol Size Distributions from Multistage Sampler Data. J. Aerosol Sci. 3:185-198.
21. Rader, D. J. and Marple, V. A. (1985). Effect of Ultra-Stokesian Drag and Particle Interception on Impactor Characteristics, Aerosol Sci. Technol. 4:141-156.
22. Rubow, K. L., Marple, V. A., Olin, J., and McCawley, M. A. (1987). A Personal Cascade Impactor: Design, Evaluation and Calibration, Am. Ind. Hyg. Assoc. J. 48:532-538.
23. Smith, J. E. and Jordan, M. L. (1964). Mathematical and Graphical Interpretation of the Log-Normal Law for Particle Size Distribution Analysis, J. Colloid Sci. 19:549-559.
24. Thiel, C. G. (2002). Cascade Impactor Data and the Lognormal Distribution: Nonlinear Regression for a Better Fit, J. Aerosol Med. 15:369-378.
25. USP 28-NF 23 (2005). Chapter 601 - Physical Tests and Determinations: Aerosols. United States Pharmacopeia, Rockville, MD, 2359-2377.